AAOI
Applied Optoelectronics, Inc.
AAOI has a slight edge over CRNT overall, supported by stronger fundamentals and stronger modeled upside.
CRNT
Ceragon Networks Ltd.
CRNT has lower modeled downside risk, despite its lower overall score.
AAOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
AAOI's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CRNT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Strong |
CRNT's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
AAOI PE Valuation
AAOI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
CRNT PE Valuation
CRNT has no meaningful PE right now: it lost money over the past year.
AAOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AAOI to return to profit, with revenue growing. However, they disagree widely on these estimates.
CRNT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CRNT, with profitability improving. However, they disagree widely on these estimates.
AAOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.98 | — |
| Q3 2026 | -$0.42 | +$3.02 |
| Q2 2026 | -$0.77 | +$2.81 |
| Q1 2026 | -$0.65 | +$3.43 |
| Q4 2025 | -$0.64 | +$3.86 |
| Q3 2025 | -$3.44 | -$1.41 |
| Q2 2025 | -$3.58 | -$1.70 |
| Q1 2025 | -$4.08 | -$2.29 |
| Q4 2024 | -$4.50 | -$2.75 |
AAOI is still losing money, but far less than before: $0.42 per share over the past year, against $4.50 at its worst in late 2024.
CRNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.14 | — |
| Q2 2026 | -$0.04 | -125% |
| Q1 2026 | -$0.03 | -112% |
| Q4 2025 | -$0.02 | -107% |
| Q3 2025 | $0.02 | -91% |
| Q2 2025 | $0.16 | +33% |
| Q1 2025 | $0.26 | +420% |
| Q4 2024 | $0.27 | +286% |
| Q3 2024 | $0.22 | +340% |
CRNT has swung to a loss: it lost $0.04 per share over the past year, after a profit the year before.
AAOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $269.9M | +127% |
| Q2 2026 | $191.9M | +86% |
| Q1 2026 | $151.1M | +51% |
| Q4 2025 | $134.3M | +34% |
| Q3 2025 | $118.6M | +82% |
| Q2 2025 | $103M | +138% |
| Q1 2025 | $99.9M | +146% |
| Q4 2024 | $100.3M | +66% |
AAOI has the edge over CRNT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +15 points |
| Q2 2026 | -13% | +2.6 points |
| Q1 2026 | -8.6% | +0.3 points |
| Q4 2025 | -8.6% | -2.1 points |
| Q3 2025 | -15% | +10 points |
| Q2 2025 | -16% | +45 points |
| Q1 2025 | -8.9% | +44 points |
| Q4 2024 | -6.5% | +1 points |
AAOI's operating margin was −0.5% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
CRNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $93.9M | +14% |
| Q1 2026 | $85M | -4.1% |
| Q4 2025 | $82.3M | -23% |
| Q3 2025 | $85.5M | -17% |
| Q2 2025 | $82.3M | -14% |
| Q1 2025 | $88.7M | +0.2% |
| Q4 2024 | $106.9M | +18% |
| Q3 2024 | $102.7M | +18% |
CRNT's revenue is down over the past year, though its latest quarter was up: $94M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 0.3% | -2.7 points |
| Q1 2026 | 2.5% | +3.7 points |
| Q4 2025 | 2.1% | -6.8 points |
| Q3 2025 | 4.4% | -9.9 points |
| Q2 2025 | 3% | -7.8 points |
| Q1 2025 | -1.2% | -6 points |
| Q4 2024 | 8.9% | +4.3 points |
| Q3 2024 | 14% | +6.6 points |
CRNT has the edge over AAOI on profitability, with a higher operating margin.
AAOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$369.9M | -$291.2M |
| Q2 2026 | -$265.3M | -$174.4M |
| Q1 2026 | -$143.6M | -$64.3M |
| Q4 2025 | -$104.6M | -$51.6M |
| Q3 2025 | -$78.7M | -$58M |
| Q2 2025 | -$91M | -$86M |
| Q1 2025 | -$79.3M | -$45.1M |
| Q4 2024 | -$53M | -$48.4M |
AAOI has burned cash in almost every quarter: −$883M over the past year, against −$302M the year before.
CRNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.7M | -69% |
| Q1 2026 | $2.8M | +$4.2M |
| Q4 2025 | $8.6M | +$11.9M |
| Q3 2025 | $4.4M | -58% |
| Q2 2025 | $5.6M | +$6M |
| Q1 2025 | -$1.4M | -150% |
| Q4 2024 | -$3.2M | -142% |
| Q3 2024 | $10.6M | -2.6% |
CRNT has the edge over AAOI on cash generation, producing positive trailing cash flow while its opponent burns cash.
AAOI Net Leverage
AAOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CRNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | 0.2x | Very low |
CRNT has more cash than debt.
AAOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.8 | Oversold |
AAOI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
CRNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.9 | Neutral |
| Stochastic | 59.2 | Neutral |
CRNT's weekly RSI is 57 (neutral) and its Stochastic is 59 (neutral).
AAOI PE vs Technology Sector
AAOI has no meaningful PE right now: it lost money over the past year.
CRNT PE vs Technology Sector
| Metric | CRNT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CRNT has no meaningful PE right now: it lost money over the past year.
AAOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.2 | 34% below |
| 20 week MA | $100.6 | 47% below |
| 50 week MA | $100.3 | 47% below |
| 100 week MA | $62.3 | 15% below |
| 200 week MA | $36.9 | 43% above |
AAOI has fallen below most of its moving averages, though it's still 43% above its 200-week average.
CRNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.15 | 11% above |
| 20 week MA | $2.16 | 10% above |
| 50 week MA | $2.29 | 3.9% above |
| 100 week MA | $2.50 | 4.8% below |
| 200 week MA | $2.44 | 2.5% below |
CRNT has the edge over AAOI on trend strength, trading above more of its moving averages.
AAOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $8.77 | -24% |
| 2021 | $8.77 | $5.64 | -36% |
| 2022 | $5.64 | $1.95 | -65% |
| 2023 | $1.95 | $19.3 | +891% |
| 2024 | $19.3 | $37.7 | +95% |
| 2025 | $37.7 | $37.2 | -1.5% |
| 2026 YTD | $37.2 | $52.9 | +42% |
AAOI has the edge over CRNT on returns for 2026, with the stronger performance.
CRNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.06 | $2.86 | +39% |
| 2021 | $2.86 | $2.64 | -7.7% |
| 2022 | $2.64 | $1.90 | -28% |
| 2023 | $1.90 | $2.16 | +14% |
| 2024 | $2.16 | $4.71 | +118% |
| 2025 | $4.71 | $2.11 | -55% |
| 2026 YTD | $2.11 | $2.38 | +13% |
CRNT's yearly returns have swung widely, from +118% in 2024 to −55% in 2025. It's up 13% so far in 2026.